Programmed death-1 ligands PD-L1 and PD-L2 show distinctive and restricted patterns of expression in lymphoma subtypes
Author:
Publisher
Elsevier BV
Subject
Pathology and Forensic Medicine
Reference35 articles.
1. Lymphoma immunotherapy: current status;Zappasodi;Front Immunol,2015
2. Immune checkpoint blockade: a common denominator approach to cancer therapy;Topalian;Cancer Cell,2015
3. Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity;Chen;Nat Rev Immunol,2004
4. Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues;Ishida;Immunol Lett,2002
5. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion;Dong;Nat Med,2002
Cited by 104 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ACT001 inhibits primary central nervous system lymphoma tumor growth by enhancing the anti-tumor effect of T cells;Biomedicine & Pharmacotherapy;2024-09
2. Intra‐tumoral and peripheral blood TIGIT and PD‐1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma;American Journal of Hematology;2024-08-17
3. Anaplastic Large-cell Lymphoma in Children: State of the Art in 2023;Journal of Pediatric Hematology/Oncology;2024-06-24
4. Programmed Death Ligand 1 (PD-L1) Expression in Lymphomas: State of the Art;International Journal of Molecular Sciences;2024-06-11
5. Targeting HDACs for diffuse large B-cell lymphoma therapy;Scientific Reports;2024-01-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3